Randomized controlled trial shows clonidine reduces opioid consumption and shivering in postoperative endometriosis patients, indicating improved pain management.
BACKGROUND: Patients with endometriosis undergoing surgery are at risk of moderate-to-severe postoperative pain. Clonidine, an alpha-2 agonist with analgesic properties, may improve multimodal pain management in these patients. METHODS: We conducted a randomized, blinded, placebo-controlled trial to investigate the effect of a single intraoperative dose of clonidine on postoperative opioid consumption and pain intensity. Patients undergoing endometriosis surgery at Aarhus University Hospital, Denmark, were randomized 1:1 to receive either intravenous clonidine (150 µg) or placebo intraoperatively. Our primary outcome was cumulative opioid consumption (intravenous morphine equivalents) 3 hours after surgery. Secondary outcomes included opioid consumption at 6 hours, pain intensity at rest and during coughing, shivering, postoperative nausea and vomiting, and sedation within the first 2 postoperative hours. The length of stay in the postanesthesia care unit was also recorded. RESULTS: A total of 120 women (mean ± standard deviation [SD] age 37 ± 7 years) were included in the final analysis, with 57 receiving clonidine and 63 receiving placebo. Mean (interquartile range [IQR]) postoperative intravenous morphine consumption during the first 3 hours was lower in the clonidine group with 5 mg (0–10) compared to 10 mg (0–16.5) in the placebo group ( P = .032). Shivering was less frequent in the clonidine group (3 vs 18 patients, P = .001). Sedation was more common in the clonidine group (21 vs 12 patients, P = .029). No differences were found between groups for pain intensity at rest and during coughing, postoperative nausea and vomiting, or length of stay in the postanesthesia care unit (PACU). CONCLUSIONS: A single intraoperative dose of clonidine is hemodynamically safe in patients undergoing endometriosis surgery and is associated with reduced postoperative opioid consumption and shivering, but increased sedation.
No takes yet. Share an insight, caveat, or question.
Birkebæk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: